Italfarmaco Provides Givinostat Update (January 2018) Italfarmaco joined PPMD for a webinar on January 24, 2018 to update the Duchenne community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 7 years ago You may also like 1:05:45 Early Pulmonary Care Webinar (September 2014) 10 years ago Care Webinars,Webinars 41:57 Translarna™ (ataluren) update (June 2014) 11 years ago Research & Clinical Trial Webinars,Webinars 1:09:01 Prosensa Update on Drisapersen (March 2014) 11 years ago Research & Clinical Trial Webinars,Webinars 1:03:22 ACT DMD Update with PTC (February 2014) 11 years ago Research & Clinical Trial Webinars,Webinars 1:05:32 Clinical Trials in Duchenne: A Behind the Scenes Look (December 2013) 11 years ago Research & Clinical Trial Webinars,Webinars 1:15:13 Update on Natural History Data Study with Dr. Craig McDonald (November 2013) 11 years ago Research & Clinical Trial Webinars,Webinars 56:44 Prosensa Update on Duchenne Program (August 2013) 11 years ago Research & Clinical Trial Webinars,Webinars 51:35 MD STARnet (March 2013) 12 years ago Research & Clinical Trial Webinars,Webinars «1…2122232425»Page 23 of 25
by: Parent Project Muscular Dystrophy
